Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-06-30
1978-12-19
Douglas, Winston A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260558P, 260558S, 260559R, 260559A, 260559T, C01B 3300, C07C10322, C07C10328, C07C10338
Patent
active
041306619
ABSTRACT:
Novel substituted benzoylacrylanilides are prepared by reacting a substituted benzoylacrylic acid with a substituted aniline in the presence of a coupling agent. These acrylanilides have significant anticoccidial activity.
REFERENCES:
patent: 3689556 (1972-09-01), Welch et al.
patent: 3825594 (1974-07-01), Houlihan
patent: 3835128 (1974-09-01), Bracha et al.
patent: 3859443 (1975-01-01), Mrozik
patent: 3880924 (1975-04-01), Grier
patent: 3975435 (1976-08-01), Nikawjtz
patent: 4048227 (1977-09-01), Mowdood
patent: 4058558 (1977-11-01), Cousse et al.
patent: 4058558 (1977-11-01), Cousse et al.
Cramer et al., "J. Amer. Pharm. Assoc.," vol. 37, No. 11, pp. 439-449, (1948).
Awad et al., C.A. 77:101065v, (1972).
Hoff Dale R.
Kulsa Peter
Mrozik Helmut H.
Doll John
Douglas Winston A.
Merck & Co. , Inc.
Patton Walter
Westlake, Jr. Harry E.
LandOfFree
Substituted benzoylacrylanilides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzoylacrylanilides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzoylacrylanilides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2373856